Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes

Nicholas P West, David B Pyne, Allan W Cripps, William G Hopkins, Dorte C Eskesen, Ashok Jairath, Claus T Christophersen, Michael A Conlon, Peter A Fricker, Nicholas P West, David B Pyne, Allan W Cripps, William G Hopkins, Dorte C Eskesen, Ashok Jairath, Claus T Christophersen, Michael A Conlon, Peter A Fricker

Abstract

Background: Probiotics purportedly reduce symptoms of gastrointestinal and upper respiratory-tract illness by modulating commensal microflora. Preventing and reducing symptoms of respiratory and gastrointestinal illness are the primary reason that dietary supplementation with probiotics are becoming increasingly popular with healthy active individuals. There is a paucity of data regarding the effectiveness of probiotics in this cohort. The aim of this study was to evaluate the effectiveness of a probiotic on faecal microbiology, self-reported illness symptoms and immunity in healthy well trained individuals.

Methods: Competitive cyclists (64 males and 35 females; age 35 ± 9 and 36 ± 9 y, VO2max 56 ± 6 and 52 ± 6 ml.kg-1.min-1, mean ± SD) were randomised to either probiotic (minimum 1 × 109 Lactobacillus fermentum (PCC®) per day) or placebo treatment for 11 weeks in a double-blind, randomised, controlled trial. The outcome measures were faecal L. fermentum counts, self-reported symptoms of illness and serum cytokines.

Results: Lactobacillus numbers increased 7.7-fold (90% confidence limits 2.1- to 28-fold) more in males on the probiotic, while there was an unclear 2.2-fold (0.2- to 18-fold) increase in females taking the probiotic. The number and duration of mild gastrointestinal symptoms were ~2-fold greater in the probiotic group. However, there was a substantial 0.7 (0.2 to 1.2) of a scale step reduction in the severity of gastrointestinal illness at the mean training load in males, which became more pronounced as training load increased. The load (duration×severity) of lower respiratory illness symptoms was less by a factor of 0.31 (99%CI; 0.07 to 0.96) in males taking the probiotic compared with placebo but increased by a factor of 2.2 (0.41 to 27) in females. Differences in use of cold and flu medication mirrored these symptoms. The observed effects on URTI had too much uncertainty for a decisive outcome. There were clear reductions in the magnitude of acute exercise-induced changes in some cytokines.

Conclusion: L. fermentum may be a useful nutritional adjunct for healthy exercising males. However, uncertainty in the effects of supplementation on URTI and on symptoms in females needs to be resolved.

Trial registration: The trial was registered in the Australia and New Zealand Clinical Trials Registry (ACTRN12611000006943).

References

    1. Pyne DB, Gleeson M. Effects of intensive exercise training on immunity in athletes. Int J Sports Med. 1998;19(Suppl 3):S183–191. doi: 10.1055/s-2007-971991. discussion S191-184.
    1. Gleeson M. Mucosal immunity and respiratory illness in elite athletes. Int J Sports Med. 2000;21(Suppl 1):S33–43. doi: 10.1055/s-2000-1450.
    1. Mackinnon LT. Chronic exercise training effects on immune function. Med Sci Sports Exerc. 2000;32(7 Suppl):S369–376.
    1. Cox AJ, Pyne DB, Saunders PU, Callister R, Gleeson M. Cytokine responses to treadmill running in healthy and illness-prone athletes. Med Sci Sports Exerc. 2007;39(11):1918–1926. doi: 10.1249/mss.0b013e318149f2aa.
    1. Gleeson M. Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev. 2000;6:5–42.
    1. Pyne DB, Hopkins WG, Batterham AM, Gleeson M, Fricker PA. Characterising the individual performance responses to mild illness in international swimmers. Br J Sports Med. 2005;39(10):752–756. doi: 10.1136/bjsm.2004.017475.
    1. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1–66.
    1. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K. et al.Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr. 2005;24(4):481–491. doi: 10.1016/j.clnu.2005.02.006.
    1. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006;6(6):374–382. doi: 10.1016/S1473-3099(06)70495-9.
    1. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr. 2010;103(1):58–68. doi: 10.1017/S0007114509991395.
    1. Kekkonen RA, Vasankari TJ, Vuorimaa T, Haahtela T, Julkunen I, Korpela R. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. Int J Sport Nutr Exerc Metab. 2007;17(4):352–363.
    1. Cox AJ, Pyne DB, Saunders PU, Fricker PA. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med. 2010;44(4):222–226. doi: 10.1136/bjsm.2007.044628.
    1. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab. 2011;21:55–64.
    1. Tiollier E, Chennaoui M, Gomez-Merino D, Drogou C, Filaire E, Guezennec CY. Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med. 2007;172(9):1006–1011.
    1. Gleeson M, Pyne DB, Callister R. The missing links in exercise effects on mucosal immunity. Exerc Immunol Rev. 2004;10:107–128.
    1. Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D. et al.PASSCLAIM--gut health and immunity. Eur J Nutr. 2004;43(Suppl 2):II118–II173. doi: 10.1007/s00394-004-1205-4.
    1. Rijkers GT, Bengmark S, Enck P, Haller D, Herz U, Kalliomaki M, Kudo S, Lenoir-Wijnkoop I, Mercenier A, Myllyluoma E. et al.Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Current Status and Recommendations for Future Research. J Nutr. 2010;140(3):671S–676S. doi: 10.3945/jn.109.113779.
    1. Barrett B, Harahan B, Brown D, Zhang Z, Brown R. Sufficiently important difference for common cold: severity reduction. Ann Fam Med. 2007;5(3):216–223. doi: 10.1370/afm.698.
    1. Larsen CN, Nielsen S, Kaestel P, Brockmann E, Bennedsen M, Christensen HR, Eskesen DC, Jacobsen BL, Michaelsen KF. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr. 2006;60(11):1284–1293. doi: 10.1038/sj.ejcn.1602450.
    1. Fricker PA, Pyne DB, Saunders PU, Cox AJ, Gleeson M, Telford RD. Influence of training loads on patterns of illness in elite distance runners. Clin J Sport Med. 2005;15(4):246–252. doi: 10.1097/01.jsm.0000168075.66874.3e.
    1. Lee H, Martin D, Anson J, Grundy D, Hahn A. Physiological characteristics of successful mountain bikers and professional road cyclists. Journal of Sports Sciences. 2002;20(12):1001–1008. doi: 10.1080/026404102321011760.
    1. Australian Institute of Health and Welfare. Australia's Health 2008. Canberra: AIHW; 2008. Cat. no. AUS 99.
    1. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28(3):495–503.
    1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389–3402. doi: 10.1093/nar/25.17.3389.
    1. Clarke K, Warwick R. A further biodiversity index applicable to species lists: variation in taxonomic distinctness. Marine Ecology-Progress Series. 2001;216:265–278. doi: 10.3354/meps216265.
    1. Denman SE, McSweeney CS. Development of a real-time PCR assay for monitoring anaerobic fungal and cellulolytic bacterial populations within the rumen. FEMS Microbiol Ecol. 2006;58(3):572–582. doi: 10.1111/j.1574-6941.2006.00190.x.
    1. Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD, de Vos WM. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol. 2002;68(1):114–123. doi: 10.1128/AEM.68.1.114-123.2002.
    1. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol. 2001;67(6):2578–2585. doi: 10.1128/AEM.67.6.2578-2585.2001.
    1. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004;97(6):1166–1177. doi: 10.1111/j.1365-2672.2004.02409.x.
    1. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70(12):7220–7228. doi: 10.1128/AEM.70.12.7220-7228.2004.
    1. Liu C, Song Y, McTeague M, Vu AW, Wexler H, Finegold SM. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol Lett. 2003;222(1):9–16. doi: 10.1016/S0378-1097(03)00296-9.
    1. Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol. 2002;40(12):4423–4427. doi: 10.1128/JCM.40.12.4423-4427.2002.
    1. Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009;41(1):3–13. doi: 10.1249/MSS.0b013e31818cb278.
    1. Sterne JA, Davey Smith G. Sifting the evidence-what's wrong with significance tests? Bmj. 2001;322(7280):226–231. doi: 10.1136/bmj.322.7280.226.
    1. Cohen J. Statistical power analysis for the behavioral sciences, Hillsdale, NJ. Lawrence Erlbaum. 1988.
    1. Grandjean AC. Diets of elite athletes: has the discipline of sports nutrition made an impact? J Nutr. 1997;127(5 Suppl):874S–877S.
    1. Campos GE, Luecke TJ, Wendeln HK, Toma K, Hagerman FC, Murray TF, Ragg KE, Ratamess NA, Kraemer WJ, Staron RS. Muscular adaptations in response to three different resistance-training regimens: specificity of repetition maximum training zones. Eur J Appl Physiol. 2002;88(1-2):50–60. doi: 10.1007/s00421-002-0681-6.
    1. Berg A, Muller HM, Rathmann S, Deibert P. The gastrointestinal system--an essential target organ of the athlete's health and physical performance. Exerc Immunol Rev. 1999;5:78–95.
    1. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmun Rev. 2008;7(8):626–630. doi: 10.1016/j.autrev.2008.06.009.
    1. Gleeson M. Can nutrition limit exercise-induced immunodepression? Nutr Rev. 2006;64(3):119–131. doi: 10.1111/j.1753-4887.2006.tb00195.x.
    1. Sherman PM, Ossa JC, Johnson-Henry K. Unraveling mechanisms of action of probiotics. Nutr Clin Pract. 2009;24(1):10–14. doi: 10.1177/0884533608329231.
    1. Gleeson M, Nieman DC, Pedersen BK. Exercise, nutrition and immune function. J Sports Sci. 2004;22(1):115–125. doi: 10.1080/0264041031000140590.
    1. Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect. 2004;6(8):767–772. doi: 10.1016/j.micinf.2004.03.010.
    1. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007;137(3 Suppl 2):781S–790S.
    1. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM, Vaneechoutte M, Van Loo J. et al.Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev. 2007;65(11):469–489. doi: 10.1111/j.1753-4887.2007.tb00272.x.
    1. Hopkins WG. Estimating sample size for magnitude-based inferences. Sports Science. 2006;10:63–70.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa